Helix Acquisition Corp. III Announces Closing of $172.5 Million Initial Public Offering, Including the Full Exercise of the Underwriter's Option to Purchase Additional Shares

Rhea-AI Summary

Helix Acquisition Corp. III (Nasdaq: HLXC) closed its initial public offering on January 26, 2026, selling 17,250,000 Class A ordinary shares at $10.00 per share, including the full 2,250,000‑share over‑allotment, producing $172,500,000 gross proceeds before underwriting discounts and offering expenses. Concurrently the sponsor purchased 497,500 Class A shares in a private placement at $10.00 for $4,975,000. The Class A shares began trading on Nasdaq under HLXC on January 23, 2026. A total of $172,500,000 of net proceeds from the IPO and private placement was placed in trust. An audited balance sheet as of January 26, 2026 will be filed on Form 8‑K.

Positive

• IPO raised $172.5M in gross proceeds at $10.00 per share
• Underwriters fully exercised 2,250,000‑share over‑allotment option
• Sponsor private placement generated $4.975M
• Total net proceeds of $172.5M placed in trust

Negative

• Gross proceeds are stated before underwriting discounts and offering expenses, which will reduce net proceeds

Argus Jan 27 session

+0.29% close to close Open Argus

Details

News Market Reaction – HLXC

On Jan 27, the day this news came out, HLXC closed 0.29% above the previous close.

Data tracked by StockTitan Argus for the Jan 27 session.

Key Figures

IPO shares issued: 17,250,000 shares IPO price: $10.00 per share IPO gross proceeds: $172,500,000 +4 more

IPO shares issued

17,250,000 shares

Class A ordinary shares in initial public offering

IPO price

$10.00 per share

Initial public offering price for Class A ordinary shares

IPO gross proceeds

$172,500,000

Gross proceeds from initial public offering before expenses

Over-allotment shares

2,250,000 shares

Shares from full exercise of underwriters’ over-allotment option

Private placement shares

497,500 shares

Class A ordinary shares in concurrent private placement

Private placement proceeds

$4,975,000

Gross proceeds from private placement at $10.00 per share

Funds placed in trust

$172,500,000

Net proceeds from IPO and private placement placed in trust

Key Terms

initial public offering, over-allotment option, private placement, prospectus, +4 more

8 terms

initial public offering financial

"it closed the initial public offering of 17,250,000 Class A"

An initial public offering (IPO) is when a private company first sells its shares to the public and becomes a stock-listed company. It matters because it allows the company to raise money from a wide range of investors, helping it grow, while giving early shareholders a way to sell some of their ownership.

over-allotment option financial

"shares issued pursuant to the full exercise by the underwriters of their over-allotment option"

An over-allotment option is a special agreement that allows underwriters to sell more shares than initially planned if demand is high. Think of it like a retailer offering extra units of a popular product to meet additional customer interest. This option helps ensure the full sale is completed and can also give investors extra shares if they want more.

private placement financial

"the Company completed a private placement of 497,500 Class A"

A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.

prospectus regulatory

"The offering was made only by means of a prospectus."

A prospectus is a detailed document that explains a company's plans for offering new shares or investments to the public. It’s important because it provides potential investors with key information about the company’s business, risks, and how they might make money, helping them decide whether to invest. Think of it as a guidebook for understanding what you're buying into.

registration statement regulatory

"A registration statement relating to these securities was declared effective"

A registration statement is a formal document that companies file with a government agency to offer new shares of stock to the public. It provides essential information about the company's finances, operations, and risks, helping investors make informed decisions. Think of it as a detailed product description that ensures transparency and trust before buying into a company.

current report on form 8-k regulatory

"included as an exhibit to a Current Report on Form 8-K to be filed"

A current report on Form 8-K is a document that publicly traded companies file to promptly share important news or events that could affect their financial position or stock price, such as major business changes or legal issues. It helps investors stay informed about timely developments, allowing them to make better decisions about buying or selling shares.

u.s. securities and exchange commission regulatory

"to be filed by the Company with the U.S. Securities and Exchange Commission"

The U.S. Securities and Exchange Commission is a government agency responsible for overseeing the stock market and protecting investors. It sets rules to ensure that companies share truthful information and that trading is fair, helping to maintain trust in the financial system. This oversight is important because it helps prevent fraud and ensures that investors can make informed decisions.

nasdaq global market financial

"shares began trading on The Nasdaq Global Market under the ticker"

The Nasdaq Global Market is a section of the stock exchange where larger, well-established companies are listed and publicly traded. It functions like a marketplace where investors can buy and sell shares of these companies, providing them with access to capital and opportunities for growth. Its role is important because it helps investors identify and invest in reputable companies with strong financial backgrounds.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

January 27, 2026

BOSTON, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Helix Acquisition Corp. III (Nasdaq: HLXC) (the “Company”) announced today that on January 26, 2026, it closed the initial public offering of 17,250,000 Class A ordinary shares, which includes 2,250,000 shares issued pursuant to the full exercise by the underwriters of their over-allotment option. The offering was priced at $10.00 per share resulting in gross proceeds of $172,500,000, before deducting underwriting discounts and commissions and other offering expenses payable by the Company.

The Company is a special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue an initial business combination target in any business or industry, it intends to focus on opportunities in healthcare or healthcare-related industries. The Company, sponsored by Helix Holdings III LLC, an affiliate of Cormorant Asset Management, is led by Bihua Chen as Chief Executive Officer and Chairperson, and Caleb Tripp as Chief Financial Officer and Chief Operating Officer.

Concurrently with the closing of the initial public offering, the Company completed a private placement of 497,500 Class A ordinary shares at a price of $10.00 per share, to Helix Holdings III LLC, generating gross proceeds to the Company of $4,975,000.

The Company’s Class A ordinary shares began trading on The Nasdaq Global Market under the ticker symbol “HLXC” on January 23, 2026.

Leerink Partners and Oppenheimer & Co. are serving as the joint bookrunning managers for the offering.

The offering was made only by means of a prospectus. Copies of the prospectus may be obtained from: Leerink Partners LLC, Attn: Syndicate Department, 53 State Street, 40th Floor, Boston, MA 02109, or by telephone at (800) 808-7525 ext. 6105, or by email at syndicate@leerink.com; and Oppenheimer & Co. Inc. Attention: Syndicate Prospectus Department, 85 Broad Street, 26th Floor, New York, NY 10004, or by telephone at (212) 667-8055, or by email at EquityProspectus@opco.com.

A total of $172,500,000 comprised of the net proceeds from the IPO and simultaneous private placement were placed in trust. An audited balance sheet of the Company as of January 26, 2026 reflecting receipt of the proceeds upon consummation of the initial public offering and the private placement will be included as an exhibit to a Current Report on Form 8-K to be filed by the Company with the U.S. Securities and Exchange Commission (the “SEC”).

A registration statement relating to these securities was declared effective by the SEC on January 22, 2026. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Forward-Looking Statements

This press release contains statements that constitute “forward-looking statements,” including with respect to the initial public offering and the anticipated use of the net proceeds. No assurance can be given that the offering discussed above will be completed on the terms described, or at all, or that the net proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and preliminary prospectus for the Company’s offering filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Investor and Media Contact

Helix Acquisition Corp. III
Caleb Tripp
Email: caleb@cormorant-asset.com 
Telephone: (857) 702-0370

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much did Helix Acquisition Corp. III (HLXC) raise in its January 2026 IPO?

The IPO sold 17,250,000 shares at $10.00 each, producing $172,500,000 in gross proceeds.

Did HLXC exercise the underwriter over‑allotment option in the IPO?

Yes; the underwriters fully exercised the 2,250,000‑share over‑allotment option.

What private placement did HLXC complete alongside the IPO on January 26, 2026?

HLXC completed a private placement of 497,500 Class A shares to its sponsor at $10.00 per share, totaling $4,975,000.

When did HLXC begin trading on Nasdaq and under what ticker?

HLXC began trading on The Nasdaq Global Market under the ticker HLXC on January 23, 2026.

What happened to the net proceeds from HLXC's IPO and private placement?

A total of $172,500,000 of net proceeds from the IPO and private placement were placed in trust.

Will HLXC file financial statements showing the IPO proceeds?

Yes; an audited balance sheet as of January 26, 2026 reflecting receipt of the proceeds will be included as an exhibit to a Form 8‑K.

What industries will HLXC target for a business combination?

HLXC is a SPAC that intends to focus on opportunities in healthcare and healthcare‑related industries.